In research published in Nature Medicine, Northwestern Medicine scientists have found a molecule that stops the growth of an aggressive pediatric brain tumor for which there is no current treatment.
A novel national trial for people with no established alternative to treat their rare cancers is being co-led by Northwestern Medicine investigators, who helped conceive of and develop the project.
Northwestern Medicine scientists have identified a molecular therapy to prevent the growth of a rare pediatric leukemia.
Feinberg’s PhD in healthcare quality and patient safety program aims to prevent 440,000 deaths each year in the United States caused by medical errors.
New research from Northwestern Medicine and the Rehabilitation Institute of Chicago scientists has identified the brain region responsible for the placebo response to pain.
Northwestern Medicine scientists have discovered circadian clocks in muscle tissue that control the muscle’s metabolic response and energy efficiency depending on the time of day.
A new pathway in the brain can be manipulated to alleviate depression, offering a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed.
Forty percent of top-selling sunscreens don’t meet national standards for protection, and consumers are spending up to 3,000 percent more for products that provide equivalent benefit, according to new research.
Ali Shilatifard, PhD, has been named the 15th recipient of the Martin E. and Gertrude G. Walder Award for Research Excellence, an honor given annually by the provost that recognizes excellence in research at Northwestern University.
New data science initiatives propel Feinberg to “the future of medicine” and individualized patient care.